14 Jul 2011
2011 Premier's Awards for Outstanding Cancer Research
View videos of the winners and special guests of the 2011 Cancer Institute NSW Premier's Awards for Outstanding Cancer Research. The awards celebrate the work and the outstanding contributions made by cancer researchers in New South Wales.
New South Wales is blessed with some brilliant research minds
and their work in cancer is giving us the evidence we need to
prevent more cancers, find cancers earlier and deliver better
cancer treatment services.
This has in turn contributed to better survival rates and
quality of life for cancer patients across the State.
You can view videos showcasing the winners and
guests of the 2011 awards below.
View and share these and other Cancer
Institute videos on our
Youtube Channel .
Interview with Vanessa Hayes
The interview with Professor Hayes by Adam Spencer, presenter of
702 ABC Sydney breakfast, was the keynote of the awards ceremony
held on 14 July 2011.
Part 1: The complexities of prostate
cancer
Part 2:
Part 3:
Part 4:
Guest speaker: Professor Vanessa Hayes
Professor Genomics Medicine at the J.Craig Venter Institute,
San Diego
Winner of the Premier's award for NSW Cancer Research Fellow
2007, a NSW/ACT Young Tall Poppy Award for Science 2008 and the
Australian Academy of Science Inaugural Ruth Stephens Gani medal
for Human Genetics in 2008, Professor Vanessa Hayes has let
technology and its applications to the field of genomics lead her
career, which has taken her around the globe.
Master of ceremonies: Adam Spencer
A consummate learner, Adam holds a first class honors degree in
Pure Mathematics and has an immense interest in science. These
passions lead Adam to hosting the ABC program QUANTUM and FAQ from
1998 to 2001.
Outstanding Cancer Researcher of the Year, 2011
Professor Roger Reddel Sir Lorimer Dods Professor and Director of Cancer Research
Unit, Children's Medical Research Institute, Westmead
Professor Reddel and his research team have contributed a
significant body of work to cancer research based on cell
immortalisation: the ability of cancerous cells to continue to
multiply and spread.
He is a pioneer in this field, which has now become a major new
body of work in cancer research. His work has the potential to lead
to broad anti-cancer treatments that could be applicable for all
tumour types.
Outstanding Cancer Research Fellow,
2011 Dr Alexander Swarbrick Garvan Institute Medical Research
Dr Alexander Swarbrick and his team have discovered that some
cancers actually make a tumour suppressing gene inactive by
producing an inhibitor, thereby allowing mutant cells to multiply,
spread and form cancers.
His research is looking closely at these inhibitors known as
microRNA. They believe understanding its behaviour can be a
powerful tool for predicting patient prognosis and may even be a
new target for therapy of some cancers.
Outstanding Cancer Research Scholar,
2011 Dr David Chang Garvan Institute Medical Research
Previously a surgeon, Dr David Chang began his research career
after securing a 12-month fellowship with Dr Andrew Biankin at the
Garvan Medical Research Institute.
Here he has worked on the biomarkers of phenotype, prognosis and
response to therapy in pancreatic cancer.
Ultimately, this will lead to the individualisation of the
treatment for each patient, so that the most appropriate therapy
could be prescribed without delay.
Innovation in Clinical Trials,
2011 Dr Meer Agar Sydney South West Palliative Care Service
Dr Meer Agar is the chief investigator at the Sydney South West
Palliative Care Service which has played a key role in leading
clinical trials for palliative cancer patients.
Taking part in clinical trials can potentially give these patients
a better quality of life.
Currently Dr Agar and her team are examining patient
disorientation and confusion that can be caused by certain
treatments.
Event details and registration
Date/Time
6:30PM, 14 Jul 2011
Please note: NSW Cancer Plan 2011-2015 , are evidence-based, not-for profit and are conducted by:
Professional colleges
Cancer councils
State-based, national and international cancer control organisations and agencies.
Cancer or health services
Government organisations
Academic institutions.
The Cancer Institute NSW will consider events that meet this criteria on a case-by-case basis, and will not support activities or groups that do not comply with strict evidence-based principles.
Top of page
